Battelle and Northwest plan radioactive implant:
This article was originally published in Clinica
Northwest Biotherapeutics and Battelle are to collaborate in developing a new type of radioactive implant for treating early-stage prostate cancer. Rather than encase radioactive isotopes in metallic "seeds", they plan to deliver them by infusing phase-changing liquid polymers into the prostate. This should simplify implantation and make treatment more effective, by allowing a wider range of isotopes to be used, say the companies.
You may also be interested in...
The maker of prestige-inspired cosmetics at value prices follows its TikTok viral success by teaming with Kathleen Belsten, aka Loserfruit, the second most-followed female gamer on the Amazon-owned livestreaming platform Twitch.
As distribution of Regeneron’s monoclonal antibody treatment for coronavirus begins, OWS officials worry about provider confusion with Lilly’s product due to differences in preparation and administration.
Join us for a brief audio tour around the past week's key developments in the global biopharma industry, in this podcast version of Scrip's Five Must-Know Things.